qPCR confirmed that the effective downstream cytokines/growth factors (VEGFa, PDGF, FGF, TNF, IGF-1 and BDNF) of these pathways are upregulated by erucamide, but they were dysregulated when we knocked down TMEM19 (Fig
Signs Your Dose May Need Adjustment Signs Your Dose May Be Too Low No improvement in sleep quality after 3-4 weeks Minimal energy changes after 6-8 weeks Lab work shows IGF-1 levels unchanged from baseline Signs Your Dose May Be Too High Water retention (puffy hands, ankles, face) Tingling or numbness in extremities Joint stiffness or discomfort Headaches, particularly in the morning Carpal tunnel-like symptoms If you experience these symptoms, contact your provider
A couple of small layout changes are added throughout the LCD screen
Investigators are particularly interested in determining the mechanisms by which effects observed in murine models relate to broader mammalian metabolic regulation, and whether different experimental conditions (young vs aged models, healthy vs metabolically compromised states) show differential responses to NNMT inhibition
